W. Dercksen

Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy.

F. Mols, G. Vreugdenhil, A. Beijers, 2014, The Journal of community and supportive oncology.

“Dear hair loss”—illness perceptions of female patients with chemotherapy-induced alopecia

A. Kaptein, A. Versluis, W. Dercksen, 2022, Supportive Care in Cancer.

Looking bad: Female patients drawing their representation of chemotherapy-induced alopecia

H. Haas, A. Kaptein, A. Versluis, 2022, Journal of health psychology.

Giving A Face to Chemotherapy-Induced Alopecia: A Feasibility Study on Drawings by Patients

E. Broadbent, R. Lugtenberg, J. Kroep, 2020, Asia-Pacific journal of oncology nursing.

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer – the SONIA study: study protocol for a randomized controlled trial

A. Jager, F. Erdkamp, A. Haringhuizen, 2018, BMC Cancer.

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane

S. Sleijfer, A. Jager, M. Jansen, 2019, Molecular oncology.

Abstract PD6-03: Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience

V. Tjan-Heijnen, J. Derhaag, C. Die-Smulders, 2017 .

Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase.

G. Peters, G. Giaccone, H. Pinedo, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancer

M. Janssen-Heijnen, M. Extermann, H. Haak, 2011, Journal of comorbidity.

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer – the SONIA study: study protocol for a randomized controlled trial

A. Jager, F. Erdkamp, A. Haringhuizen, 2018, BMC Cancer.